Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageChun‐Jen Liu, Pei‐Jer Chen, Long‐Bin Jeng et al.|Journal of Hepatology|2009Cited by 157
Cytologic Changes in Small Hepatocellular Carcinomas After Radiofrequency AblationShi-Ming Lin, Cheng‐Yuan Peng, Chien-Heng Shen et al.|Acta Cytologica|2002Cited by 11